Australia markets closed

Vaccitech plc (VACC)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
4.3000-0.0800 (-1.83%)
At close: 04:00PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
Total revenue
15,071
268
4,820
Operating expenses
Research development
22,368
16,370
11,108
Selling general and administrative
27,004
25,118
10,481
Total operating expenses
49,372
41,488
21,588
Operating income or loss
-34,301
-41,220
-16,768
Interest expense
92
2,668
3,600
Total other income/expenses net
-
-7,254
2,529
Income before tax
-33,978
-51,140
-17,839
Income tax expense
-826
-28
95.01
Income from continuing operations
-33,152
-51,112
-17,934
Net income
-33,001
-50,865
-17,706
Net income available to common shareholders
-33,001
-50,865
-17,706
Basic EPS
-
-
-371.62
Diluted EPS
-
-
-371.62
Basic average shares
-
-
47.646
Diluted average shares
-
-
47.646
EBITDA
-
-47,870
-14,030